| EPI | SMIN | EPI / SMIN | |
| Gain YTD | -7.129 | 0.143 | -4,984% |
| Net Assets | 2.03B | 757M | 268% |
| Total Expense Ratio | 0.84 | 0.74 | 114% |
| Turnover | 13.00 | 62.00 | 21% |
| Yield | 0.00 | 0.00 | - |
| Fund Existence | 18 years | 14 years | - |
| EPI | SMIN | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 4 days ago 74% | 4 days ago 69% |
| Momentum ODDS (%) | 4 days ago 79% | 4 days ago 81% |
| MACD ODDS (%) | 4 days ago 83% | 4 days ago 80% |
| TrendWeek ODDS (%) | 4 days ago 81% | 4 days ago 83% |
| TrendMonth ODDS (%) | 4 days ago 78% | 4 days ago 80% |
| Advances ODDS (%) | 4 days ago 80% | 4 days ago 84% |
| Declines ODDS (%) | 12 days ago 77% | 12 days ago 80% |
| BollingerBands ODDS (%) | 4 days ago 78% | 4 days ago 85% |
| Aroon ODDS (%) | 4 days ago 82% | 4 days ago 81% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GIDWX | 20.04 | 0.13 | +0.65% |
| Goldman Sachs US Eq Div and Premium R6 | |||
| HSIIX | 29.59 | -0.08 | -0.27% |
| Carillon Eagle Small Cap Growth I | |||
| FSMDX | 42.33 | -0.12 | -0.28% |
| Fidelity Mid Cap Index | |||
| CCWSX | 21.56 | -0.16 | -0.74% |
| Baird Chautauqua International Gr Inv | |||
| RYBOX | 71.28 | -1.65 | -2.26% |
| Rydex Biotechnology A | |||
A.I.dvisor tells us that EPI and INFY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPI and INFY's prices will move in lockstep.
| Ticker / NAME | Correlation To EPI | 1D Price Change % | ||
|---|---|---|---|---|
| EPI | 100% | +0.07% | ||
| INFY - EPI | 27% Poorly correlated | +0.67% |